Research progress of relaxin in atrial fibrillation

doi:10.11958/20201643

Tianjin Medical Journal ›› 2021, Vol. 49 ›› Issue (4): 441-444.doi: 10.11958/20201643

• Review • Previous Articles Next Articles

Research progress of relaxin in atrial fibrillation

LI Rui-ling, ZHAO Zhi-qiang△

Department of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin Institute of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin 300211, China

Received:2020-06-11 Revised:2021-01-05 Published:2021-04-15 Online:2021-04-16
Contact: ZHAO Zhi-qiang E-mail:zzqzzqzhiqiang@163.com

LI Rui-ling, ZHAO Zhi-qiang△. Research progress of relaxin in atrial fibrillation[J]. Tianjin Medical Journal, 2021, 49(4): 441-444.

Abstract

Abstract: Atrial fibrillation (AF) is a common persistent arrhythmia. Its mechanism is still unclear, involving electrical remodeling, structural remodeling, inflammatory response, oxidative stress and many other aspects. Recent studies on relaxin (RLX) have shown that relaxin plays an important role in the cardiovascular system. This paper summarizes the potential role of RLX in AF and its related mechanisms, which provides a new way for the prevention and treatment of AF.

Key words: atrial fibrillation, relaxin, atrial remodeling, matrix metalloproteinases

CLC Number:

R541.75

[1]	GAO Pan, XIE Bingxin, ZHOU Zandong, LIU Tong. Promoting effect of circulating FGF23 on atrial fibrosis in chronic kidney disease [J]. Tianjin Medical Journal, 2024, 52(9): 917-923.
[2]	ZHANG Minglong, FANG Yuanyuan, SUI Xiaopeng, CHEN Xinxin, LI Liudong, WANG Haitao. Relationship between left ventricular hypertrophy diagnosed by Peguero-Lo-Presti index and recurrence after radiofrequency catheter ablation of paroxysmal atrial fibrillation [J]. Tianjin Medical Journal, 2024, 52(2): 210-214.
[3]	HUO Liwei, LIU Jun, ZHENG Binbin, BI Xuena. Predictive value of serum FGF-23 in recurrence of patients with atrial fibrillation after radiofrequency ablation [J]. Tianjin Medical Journal, 2023, 51(1): 74-77.
[4]	XING Jianong, LIANG Zhuo, XING Aijun, LIU Junlan, PENG Hongchao, ZHANG Tianhua, ZHANG Chunlai. Effects of lncRNA MIAT on ventricular remodeling and myocardial fibrosis in rats with atrial fibrillation through targeting regulation of miR-128-3p [J]. Tianjin Medical Journal, 2022, 50(9): 932-937.
[5]	HE Hongmei, SUN Jian, WANG Huanhuan, MA Shujing, ZHANG Haiyan, ZOU Yu'an, XUE Qian, SONG Aixia. Risk factors for vascular dementia in patients with nonvalvular atrial fibrillation: a case-control study [J]. Tianjin Medical Journal, 2022, 50(8): 840-843.
[6]	ZHANG Xuteng, LIU Fang, CHEN Jun, LIU Xiaomeng, JIN Le, GAO Hongmei△. Research progress of PI3K/AKT signaling pathway in atrial fibrillation [J]. Tianjin Medical Journal, 2022, 50(5): 556-560.
[7]	HUO Ning, ZHAN Xiaoping, ZHOU Mengzhu, ZHANG Yue, LIANG Xue, LI Guangping, LIU Changle. Effects of glyburide on atrial remodeling and atrial fibrillation induction in diabetic rats [J]. Tianjin Medical Journal, 2022, 50(3): 253-258.
[8]	LU Jie, ZHANG Xin, WANG Tao, YANG Ning. Effects of circRNAs on atrial fibrillation and its mechanism [J]. Tianjin Medical Journal, 2022, 50(3): 333-336.
[9]	FENG Hui-qiong, DONG Feng, MENG Xiang-jun, NIU Wen-liang, XI Fu-qiang, WANG Wei. Predictive value of serum pentraxin-3 combined with CHA2DS2-VASc score for cerebral infarction in patients with obstructive sleep apnea hypopnea syndrome and atrial fibrillation [J]. Tianjin Medical Journal, 2021, 49(12): 1324-1327.
[10]	SHAO Qing-miao, ZHANG Tao, LIU Tong, LI Guang-ping . Research progress of SGLT2 inhibitor in the occurrence of atrial fibrillation [J]. Tianjin Medical Journal, 2021, 49(10): 1116-1120.
[11]	WANG Hao-jie, LIANG Bing△, ZHAO Hui, JING Yuan-hu, ZHANG Pei, SHI Gong-ning. The predictive value of NLR combined with hs-cTnT on atrial fibrillation after off-pump coronary artery bypass grafting [J]. Tianjin Medical Journal, 2020, 48(10): 966-969.
[12]	MA Tian-yi, ZHONG Jiang-hua, SU Yu-jiang, ZHOU Zhi-hong, YANG Hui, YANG Chao-ying. Relationship between plasma big endothelin-1 level and prognosis of paroxysmal atrial fibrillation [J]. Tianjin Medical Journal, 2019, 47(8): 833-837.
[13]	ZHANG Xiao-wei, LI Guang-ping, LIU Tong. Progress in endoplasmic reticulum stress and atrial fibrillation [J]. Tianjin Medical Journal, 2019, 47(3): 317-321.
[14]	WU Xiao-han, LIU Chang-le. Advances in NLRP3 inflammasome and atrial fibrillation [J]. Tianjin Medical Journal, 2019, 47(3): 329-332.
[15]	LI Zhan-feng, HAN Yi. Changes of endogenous nociceptin/orphanin FQ (N/OFQ) and C-reactive protein in elderly patients with atrial fibrillation before joint replacement [J]. Tianjin Medical Journal, 2019, 47(12): 1230-1234.

Research progress of relaxin in atrial fibrillation

Cite this article

PDF (PC)

Knowledge

Abstract

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments